prednisolone has been researched along with Anti-Glomerular Basement Membrane Disease in 40 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Anti-Glomerular Basement Membrane Disease: An autoimmune disease of the KIDNEY and the LUNG. It is characterized by the presence of circulating autoantibodies targeting the epitopes in the non-collagenous domains of COLLAGEN TYPE IV in the basement membranes of kidney glomeruli (KIDNEY GLOMERULUS) and lung alveoli (PULMONARY ALVEOLI), and the subsequent destruction of these basement membranes. Clinical features include pulmonary alveolar hemorrhage and glomerulonephritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " When treating rapidly progressive glomerulonephritis, immunosuppressive status should be carefully monitored regarding not only the dosage of therapeutic regimen but also the mental health status and nutrition of the patient." | 1.37 | A case of Goodpasture syndrome positive for anti-GBM antibody and MPO-ANCA complicated by a variety of serious infections. ( Adachi, T; Hatta, T; Kimura, T; Kishimoto, N; Kusaba, T; Matsubara, H; Mori, Y; Nakagawa, H; Nakayama, M; Okigaki, M; Sakoda, C; Sonomura, K, 2011) |
| "We considered this to be a rare case of Goodpasture's syndrome associated with not only anti-GBM antibodies, but also MPO-ANCA." | 1.30 | [An experience of treatment of double positive myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and anti-glomerular basement membrane antibodies in Goodpasture's syndrome onset of crescentic glomerulonephritis]. ( Hasegawa, H; Hashimoto, S; Hiruma, S; Imada, A; Iwamoto, I; Kanamaru, A; Maekura, S; Naiki, Y; Sakaguchi, M; Takeda, T; Tanaka, H; Yamazumi, T; Yonekawa, S, 1998) |
| "The requirements for a diagnosis of Goodpasture's syndrome (GPS) include: (1) the presence of glomerulonephritis, (2) alveolar bleeding, and (3) the presence of anti-glomerular basement membrane (anti-GBM antibody)." | 1.29 | Two cases of Goodpasture's syndrome--clinicopathological studies and relapse. ( Hasegawa, M; Katsumata, H; Kawamura, N; Kojima, K; Kushimoto, H; Murakami, K; Okada, Y; Tomita, M; Yamasita, H; Yanai, T, 1993) |
| "Treatment with prednisolone, cytotoxic drugs, and plasma exchange hastened the time to clearance of autoantibody and improved the outlook of patients who were not dependent on dialysis and those with lung haemorrhage." | 1.27 | Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. ( Bowman, C; Lockwood, CM; Pusey, CD; Rees, AJ; Savage, CO, 1986) |
| "Two further patients with Goodpasture's syndrome were treated." | 1.26 | Immunosuppression and the additive effect of plasma exchange in treatment of rapidly progressive glomerulonephritis. ( Bengtsson, U; Brun, C; Bygren, P; Jonsson, M; Jørgensen, F; Larsen, S; Laurell, AB; Lindholm, T; Norlin, M; Sjöholm, A; Thysell, H, 1982) |
| "Seven patients with Goodpasture's syndrome induced by anti-glomerular-basement-membrane (anti-G." | 1.26 | Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. ( Evans, DJ; Lockwood, CM; Pearson, TA; Peters, DK; Rees, AJ; Wilson, CB, 1976) |
| "A patient with Goodpasture's syndrome has recovered after treatment with immunosuppressive drugs (cyclophosphamide and prednisolone) and removal of circulating antibodies by plasma exchange." | 1.25 | Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis. ( Boulton-Jones, JM; Lockwood, CM; Lowenthal, RM; Peters, DK; Simpson, IJ, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (52.50) | 18.7374 |
| 1990's | 4 (10.00) | 18.2507 |
| 2000's | 9 (22.50) | 29.6817 |
| 2010's | 6 (15.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Philipse, E | 1 |
| Van Marck, V | 1 |
| Verpooten, GA | 1 |
| Janssen van Doorn, K | 1 |
| Naidoo, S | 1 |
| Waller, S | 1 |
| Takeda, Y | 1 |
| Abe, A | 1 |
| Toki, T | 1 |
| Komaba, H | 1 |
| Abe, T | 1 |
| Umezu, M | 1 |
| Joh, K | 1 |
| Fukagawa, M | 1 |
| Artunc, F | 1 |
| Dorn, C | 1 |
| Gehlen, F | 1 |
| Büttner, M | 1 |
| Amann, K | 1 |
| Weyrich, P | 1 |
| Heyne, N | 1 |
| Wolf, S | 1 |
| Shah, Y | 1 |
| Mohiuddin, A | 1 |
| Sluman, C | 1 |
| Daryanani, I | 1 |
| Ledson, T | 1 |
| Banerjee, A | 1 |
| Crowe, A | 1 |
| McClelland, P | 1 |
| Sakoda, C | 1 |
| Kusaba, T | 1 |
| Adachi, T | 1 |
| Sonomura, K | 1 |
| Kimura, T | 1 |
| Nakayama, M | 1 |
| Kishimoto, N | 1 |
| Nakagawa, H | 1 |
| Okigaki, M | 1 |
| Hatta, T | 1 |
| Matsubara, H | 1 |
| Mori, Y | 1 |
| Nakabayashi, K | 1 |
| Fujioka, Y | 1 |
| Arimura, Y | 1 |
| Fukuoka, T | 1 |
| Marumo, T | 1 |
| Umino, M | 1 |
| Kamiya, Y | 1 |
| Okai, T | 1 |
| Tsurumaki, S | 1 |
| Nagasawa, T | 2 |
| Yamada, A | 2 |
| Bayat, A | 1 |
| Kamperis, K | 1 |
| Herlin, T | 1 |
| Pusey, CD | 3 |
| Nojima, Y | 1 |
| Kitaura, K | 1 |
| Asano, K | 1 |
| Naumann d'Alnoncourt, C | 1 |
| Thysell, H | 1 |
| Bygren, P | 1 |
| Bengtsson, U | 1 |
| Lindholm, T | 1 |
| Norlin, M | 1 |
| Jonsson, M | 1 |
| Brun, C | 1 |
| Larsen, S | 1 |
| Jørgensen, F | 1 |
| Sjöholm, A | 1 |
| Laurell, AB | 1 |
| Boyle, PD | 1 |
| Balmer, JP | 1 |
| Craswell, PW | 1 |
| Johnson, FL | 1 |
| Glöckner, WM | 1 |
| Dienst, C | 1 |
| Kindler, J | 1 |
| Sieberth, HG | 1 |
| Kojima, K | 2 |
| Okada, Y | 1 |
| Kushimoto, H | 1 |
| Kawamura, N | 1 |
| Katsumata, H | 1 |
| Murakami, K | 1 |
| Yamasita, H | 1 |
| Tomita, M | 1 |
| Hasegawa, M | 1 |
| Yanai, T | 1 |
| Usutani, S | 1 |
| Nosaka, H | 1 |
| Shirai, M | 1 |
| Akimoto, H | 1 |
| Shimomura, M | 1 |
| Kakuta, S | 1 |
| Nagase, M | 1 |
| Sado, Y | 1 |
| Solov'eva, OA | 1 |
| Ianushkevich, TN | 1 |
| Varshavskiĭ, VA | 1 |
| Miroshnichenko, NG | 1 |
| Burnevich, EZ | 1 |
| Kozlovskaia, LV | 1 |
| Takeda, T | 2 |
| Naiki, Y | 1 |
| Yonekawa, S | 1 |
| Sakaguchi, M | 1 |
| Iwamoto, I | 1 |
| Tanaka, H | 1 |
| Hasegawa, H | 1 |
| Imada, A | 1 |
| Kanamaru, A | 1 |
| Hiruma, S | 1 |
| Maekura, S | 1 |
| Hashimoto, S | 1 |
| Yamazumi, T | 1 |
| Sano, T | 1 |
| Kamata, K | 1 |
| Shigematsu, H | 1 |
| Kobayashi, Y | 1 |
| Levy, JB | 1 |
| Turner, AN | 1 |
| Rees, AJ | 3 |
| Lockwood, CM | 3 |
| Pearson, TA | 1 |
| Evans, DJ | 1 |
| Peters, DK | 2 |
| Wilson, CB | 1 |
| Misiani, R | 1 |
| Bertani, T | 1 |
| Licini, R | 1 |
| Remuzzi, G | 1 |
| Mecca, G | 1 |
| Ozsoylu, S | 1 |
| Hicsonmez, G | 1 |
| Berkel, I | 1 |
| Say, B | 1 |
| Tinaztepe, B | 1 |
| McKenzie, PE | 1 |
| Taylor, AE | 1 |
| Woodroffe, AJ | 1 |
| Seymour, AE | 1 |
| Chan, YL | 1 |
| Clarkson, AR | 1 |
| Boulton-Jones, JM | 1 |
| Lowenthal, RM | 1 |
| Simpson, IJ | 1 |
| Hayashi, H | 1 |
| Tsuiki, T | 1 |
| Kato, T | 1 |
| Savage, CO | 1 |
| Bowman, C | 1 |
| Parizhskiĭ, ZM | 1 |
| Shishkin, VI | 1 |
| Whitworth, JA | 1 |
| Lawrence, JR | 1 |
| Meadows, R | 1 |
| Stummvoll, HK | 1 |
| Pinggera, WF | 1 |
| Wolf, A | 1 |
| Seidl, G | 1 |
| Lobenwein, E | 1 |
| Oppolzer, R | 1 |
| Seeliger, K | 1 |
| Huland, H | 1 |
| Johnson, JR | 1 |
| McGovern, VJ | 1 |
| Cameron, JS | 1 |
| Gossain, VV | 1 |
| Gerstein, AR | 1 |
| Janes, AW | 1 |
| Seaton, A | 1 |
| Meland, JM | 1 |
| Lapp, NL | 1 |
| Heale, WF | 1 |
| Matthiesson, AM | 1 |
| Niall, JF | 1 |
4 reviews available for prednisolone and Anti-Glomerular Basement Membrane Disease
| Article | Year |
|---|---|
Characteristics and outcome of Goodpasture's disease in children.
Topics: Adolescent; Anti-Glomerular Basement Membrane Disease; Female; Glucocorticoids; Humans; Methylpredni | 2012 |
[Goodpasture syndrome].
Topics: Acute Disease; Anti-Glomerular Basement Membrane Disease; Autoantibodies; Basement Membrane; Biomark | 2005 |
[Anti-GBM disease].
Topics: Anti-Glomerular Basement Membrane Disease; Antibodies; Autoantibodies; Autoantigens; Biomarkers; Col | 2005 |
Immunosuppressant agents in the treatment of glomerulonephritis. 2. Cytotoxic drugs.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Antilymphocyte Serum; Antineoplastic Agents; Azath | 1971 |
36 other studies available for prednisolone and Anti-Glomerular Basement Membrane Disease
| Article | Year |
|---|---|
A patient with oliguria and hemoptysis: do not forget the lung-kidney connection!
Topics: Anti-Glomerular Basement Membrane Disease; Female; Glucocorticoids; Hemoptysis; Humans; Immunoglobul | 2014 |
Anti-GBM antibodies co-exist with MPO-ANCA in a 4-year-old girl with acute renal failure.
Topics: Acute Kidney Injury; Anti-Glomerular Basement Membrane Disease; Antibodies, Antineutrophil Cytoplasm | 2009 |
[Case of goodpasture syndrome associated with minimal change nephrotic syndrome (MCNS) in a patient with rheumatoid arthritis (RA)].
Topics: Anti-Glomerular Basement Membrane Disease; Arthritis, Rheumatoid; Female; Humans; Kidney; Methylpred | 2009 |
[79-year-old patient with pulmorenal syndrome].
Topics: Acute Kidney Injury; Aged; Anti-Glomerular Basement Membrane Disease; Antibodies, Antineutrophil Cyt | 2010 |
Rituximab in anti-glomerular basement membrane disease.
Topics: Adolescent; Anti-Glomerular Basement Membrane Disease; Antibodies, Monoclonal, Murine-Derived; Gluco | 2012 |
A case of Goodpasture syndrome positive for anti-GBM antibody and MPO-ANCA complicated by a variety of serious infections.
Topics: Anti-Glomerular Basement Membrane Disease; Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; B | 2011 |
Anti-glomerular basement membrane (anti-GBM) disease accompanied by vasculitis that was not positive for antineutrophil cytoplasmic antibodies to myeloperoxidase and proteinase 3: a report of two cases and the incidence of anti-GBM disease at one institut
Topics: Adult; Aged; Anti-Glomerular Basement Membrane Disease; Antibodies, Antineutrophil Cytoplasmic; Fema | 2011 |
Anti-glomerular basement membrane disease.
Topics: Anti-Glomerular Basement Membrane Disease; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, | 2003 |
[A case of anti-GBM-antibody positive rapidly progressive glomerulonephritis who was weaned from hemodialysis after combination therapy with steroid and plasmapheresis].
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Anti-Inflammatory Agents; Antibodies; Autoantibodi | 2005 |
[21-year-old bricklayer with hemoptysis and hematuria].
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Combined Modality Therapy; Cyclophosphamide; Diagn | 1983 |
Immunosuppression and the additive effect of plasma exchange in treatment of rapidly progressive glomerulonephritis.
Topics: Adult; Aged; Anti-Glomerular Basement Membrane Disease; Antibodies; Aspirin; Azathioprine; Cyclophos | 1982 |
Multiple-site avascular necrosis. A complication of Goodpasture's syndrome treated with plasma exchange and corticosteroids.
Topics: Adrenal Cortex Hormones; Adult; Anti-Glomerular Basement Membrane Disease; Cyclophosphamide; Humans; | 1982 |
[Plasma exchange in rapidly progressive glomerulonephritis (author's transl)].
Topics: Adolescent; Adult; Aged; Anti-Glomerular Basement Membrane Disease; Antigen-Antibody Complex; Azathi | 1981 |
Two cases of Goodpasture's syndrome--clinicopathological studies and relapse.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Cyclophosphamide; Humans; Male; Middle Aged; Plasm | 1993 |
[A case of anti-basement membrane (BM) mediated disease presenting renal and pulmonary symptoms by divergent timing].
Topics: Anti-Glomerular Basement Membrane Disease; Autoantibodies; Basement Membrane; Biomarkers; Hemorrhage | 1997 |
[Possible remission induction of extracapillary glomerulonephritis with crescents: case report].
Topics: Anti-Bacterial Agents; Anti-Glomerular Basement Membrane Disease; Biopsy; Drug Therapy, Combination; | 1998 |
[An experience of treatment of double positive myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and anti-glomerular basement membrane antibodies in Goodpasture's syndrome onset of crescentic glomerulonephritis].
Topics: Aged; Anti-Glomerular Basement Membrane Disease; Anti-Inflammatory Agents; Antibodies; Antibodies, A | 1998 |
A case of anti-glomerular basement membrane glomerulonephritis superimposed on membranous nephropathy.
Topics: Anti-Glomerular Basement Membrane Disease; Female; Glomerulonephritis, Membranous; Humans; Immunosup | 2000 |
Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.
Topics: Adolescent; Adult; Aged; Anti-Glomerular Basement Membrane Disease; Combined Modality Therapy; Creat | 2001 |
Summaries for patients. Long-term outcome of patients with kidney damage due to Goodpasture disease wo receive very intensive treatment.
Topics: Adolescent; Adult; Aged; Anti-Glomerular Basement Membrane Disease; Combined Modality Therapy; Cyclo | 2001 |
Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome.
Topics: Adolescent; Adult; Anti-Glomerular Basement Membrane Disease; Autoantibodies; Azathioprine; Basement | 1976 |
Asphyxia in Goodpasture's syndrome: Early treatment by immunosuppression and plasma exchange.
Topics: Anti-Glomerular Basement Membrane Disease; Asphyxia; Cyclophosphamide; Humans; Male; Middle Aged; Pl | 1978 |
Goodpasture's syndrome (pulmonary hemosiderosis with nephritis).
Topics: Anemia, Hemolytic; Anemia, Hypochromic; Anti-Glomerular Basement Membrane Disease; Biopsy; Blood Tra | 1976 |
Plasmapheresis in glomerulonephritis.
Topics: Adolescent; Adult; Agammaglobulinemia; Anti-Glomerular Basement Membrane Disease; Complement System | 1979 |
Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Antibodies; Basement Membrane; Cyclophosphamide; H | 1975 |
[A case presenting diffuse pulmonary bleeding and gross hematuria similarly to Goodpasture's syndrome].
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Antibodies; Autoantibodies; Diagnosis, Differentia | 1989 |
Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4.
Topics: Adolescent; Adult; Aged; Anti-Glomerular Basement Membrane Disease; Autoantibodies; Basement Membran | 1986 |
[Favorable clinical outcome of Goodpasture's syndrome].
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Dexamethasone; Drug Therapy, Combination; Humans; | 1988 |
[Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and the therapeutic methods. Organ-specific autoimmune diseases. 5) Anti-GBM antibody diseases].
Topics: Anti-Glomerular Basement Membrane Disease; Antibodies; Autoantibodies; Glomerulonephritis; Humans; I | 1988 |
Goodpasture's syndrome. A review of nine cases and an evaluation of therapy.
Topics: Adolescent; Adult; Anti-Glomerular Basement Membrane Disease; Autopsy; Azathioprine; Biopsy; Dipyrid | 1974 |
[Hemoptysis and glomerulonephritis, Clinical aspects and differential diagnosis of the Goodpasture's syndrome].
Topics: Adolescent; Adult; Anti-Glomerular Basement Membrane Disease; Antibody Formation; Azathioprine; Coug | 1974 |
[Etiology of Goodpasture's syndrome].
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Antibody Formation; Autoantibodies; Autopsy; Basem | 1973 |
Focal necrotizing glomerulonephritis.
Topics: Adolescent; Adult; Aged; Anti-Glomerular Basement Membrane Disease; Biopsy; Blood Urea Nitrogen; Cap | 1973 |
Goodpasture's syndrome: a familial occurrence.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Glomerulonephritis; Humans; Kidney Glomerulus; Mal | 1972 |
Remission in Goodpasture's syndrome: report of two patients treated by immunosuppression and review of the literature.
Topics: Anti-Glomerular Basement Membrane Disease; Azathioprine; Chlorambucil; Humans; Immunosuppression The | 1971 |
Lung haemorrhage and nephritis (Goodpasture's syndrome).
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Humans; Male; Middle Aged; Prednisolone; Renal Dia | 1969 |